Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...
Commencement of LEADLESS II clinical research trial represents important milestone in bringing transformational pacing technology to U.S. patients ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, ...